Jury orders J & J to pay $550 million in Missouri asbestos cancer case

A Missouri jury on Thursday found Johnson&Johnson liable in a lawsuit filed by 22 women who alleged the company's talc-based products, including J&J Baby Powder, contain asbestos and caused them ovarian cancer, and ordered the company to pay $550 million in compensatory damages.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

University of Leicester researchers soon will open the first molecularly stratified clinical trial for malignant mesothelioma with the hope of moving the future of treatment toward more personalization. The phase II trial in the United Kingdom is designed to match therapy with a patient’s specific genetic profile. “We’re trying to bring the right drug to the right patient at the right time,” Professor Dean Fennell, chair of thoracic medical oncology at Leicester and chief trial investigator, told Asbestos.com. “We need to find different treatments that work for different people. This is a step...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
ConclusionsReduction of postoperative complications after CRS –HIPEC is essential for optimal short- and long-term outcomes. For assessing total burden of postoperative complications per patient, CCI is superior to CDC and more sensitive for assessing surgery- and cancer-related outcomes after CRS–HIPEC.
Source: Annals of Surgical Oncology - Category: Cancer & Oncology Source Type: research
Johnson &Johnson’s latest trial over claims its iconic baby powder causes mesothelioma ended in mistrial this week after a California jury couldn’t reach a decision in the case of school counselor Carolyn Weirick. Lawyers for Weirick asked jurors for $25 million in compensation for past and future pain and suffering related to her mesothelioma, a rare cancer linked to asbestos exposure. Weirick, 59, was diagnosed with mesothelioma in 2017 and said her only exposure to asbestos came from the use of J&J’s talc-based products for more than 40 years. A state judge in Pasadena, California, declared a mistr...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Standard-of-care treatment for patients with pleural mesothelioma may soon include Tumor Treating Fields (TTF), a novel therapy involving electric currents that disrupt cancer cell division and inhibit tumor growth. In the wake of recently released results from Novocure’s STELLAR phase II clinical trial, the U.S. Food and Drug Administration (FDA) is expected to approve the treatment within the next six months, giving mesothelioma patients another much-needed option. “At this point, it should be a relatively rapid approval process,” Dr. Eilon Kirson, chief science officer at Novocure, the oncology company...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Conclusion: Therefore, efforts to reduce future OBDs of ARDs, including early detection and proper management of ARDs, are needed in Korea. PMID: 30140191 [PubMed - in process]
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
A Missouri trial court judge has affirmed the massive $4.69 billion verdict against Johnson&Johnson in a case involving 22 women and their families who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
This study strengthens the suspicion that, next to germline BAP1 alterations, other genetic factors might predispose families to the development of MM,” the authors wrote. Mutations in only one gene called BAP1 have been shown to increase risk of mesothelioma. However, experts suspect other genes may play a role in the disease. This new study supports the idea that other genes can predispose a person — or even an entire family — to mesothelioma. Hints of Genetic Influence on Mesothelioma Risk Asbestos exposure is the No. 1 cause of mesothelioma. However, some families seem to have more cases of mesothe...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Conditions:   Peritoneal Mesothelioma;   Fallopian Tube Adenocarcinoma;   Adenocarcinoma of the Ovary;   Primary Peritoneal Carcinoma Intervention:   Biological: MCY-M11 Sponsors:   MaxCyte, Inc.;   CTI Clinical Trial and Consulting Services Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Wall Street is trying to figure out whether the U.S. insurance industry will bear any costs from a record $4.69 billion judgment against Johnson&Johnson awarded to customers and their families who claimed that asbestos-contaminated talc caused ovarian cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Studies conducted in people have mixed results, with some indication of increased risk of ovarian cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Nursing, Oncology, Pathology, Pharmacy, Institutional, Source Type: news
More News: Asbestosis | Babies | Cancer | Cancer & Oncology | Health | Lawsuits | Legislation | Ovarian Cancer | Ovaries | Women